The Daily Index — Thursday, July 4, 2024 · TLDR Index

Across today’s newsletters

Today’s Index

TLDR

NOPLACE, A MASHUP OF TWITTER AND MYSPACE FOR GEN Z, HITS NO. 1 ON THE APP STORE

noplace, an app that aims to bring the 'social' back to 'social media', has surged to the top of the iOS App Store. Launched out of invite-only mode on Wednesday, the app allows users to have colorful customizable profiles and share everything from relationship status to what they're listening or watching, what they're reading or doing, and more. It focuses on text-based updates and currently doesn't support photos or videos. The app offers a feed with friends and another global feed from everyone in the app - both are in reverse chronological order. It uses AI technology to drive suggestions and creation and create summaries for things users may have missed.

techcrunch.com · 6 min

TLDR AI

GROK 2 ANNOUNCED FOR AUGUST

xAI's next model is slated for August. It reportedly took 20k H100s to train. Grok 3 is rumored for the end of the year and potentially requires 100k H100s.

links.tldrnewsletter.com · 1 min

TLDR Web Dev

PROFILING NODE.JS APPLICATIONS

This guide explores profiling techniques to pinpoint high CPU usage in Node.js applications. It covers using built-in profilers, Chrome DevTools, the Node Inspector API, and the perf tool. The guide also mentions continuous profiling for ongoing monitoring and explores memory leak detection.

betterstack.com · 13 min

TLDR Crypto

ETHEREUM ETFS COULD COME AS SOON AS NEXT WEEK

Bitwise has filed an amended S-1 form for its Ethereum ETF, potentially allowing the product to launch as soon as next week, pending SEC approval. Analysts suggest that the listing, which follows the SEC's earlier approval of 19b-4 forms for eight Ethereum ETFs in May, could happen by mid-July.

theblock.co · 2 min

TLDR Design

META'S NEW TEXT-TO-3D GENERATOR CREATES 3D MODELS IN UNDER A MINUTE

Meta's new 3D Gen platform allows rapid text-to-3D asset creation, generating high-quality 3D models with advanced geometry and texture in under a minute. This system, which utilizes AssetGen and TextureGen, enhances content creation speed and quality. It has been deemed superior to prior state-of-the-art methods and is preferred by professional 3D artists. With significant control over mesh models and texture maps, 3D Gen supports iterative refinement, making it highly effective for real-world modeling and rendering applications.

petapixel.com · 2 min

TLDR

THREADS HITS 175 MILLION USERS AFTER A YEAR

Threads has reached more than 175 million monthly active users. Launched on the App Store last year on July 5, the app is still growing steadily. Meta hasn't shared daily user numbers, suggesting that Threads is getting a lot of traffic from people who have yet to become regular users. Much of the app's growth is still coming from it being promoted inside Instagram. Meta is considering turning on ads in Threads sometime next year.

theverge.com · 3 min

TLDR

SPACEX WILL ATTEMPT THE FIRST COMMERCIAL SPACEWALK

Polaris Dawn, a mission designed to purchase the limits of SpaceX's technology and help pave the way for a longer-term human presence in space, is now set to launch no earlier than July 12. It will be SpaceX's second all-civilian mission and the first in its Polaris program. The mission plans include the first commercial spacewalk, research on human health in space, and tests to equip the spacecraft with Starlink Wi-Fi. It will reach an orbit of over 800 miles above Earth, the furthest out a human has gone from the planet since the Apollo era.

popsci.com · 4 min

TLDR

‘SKINNY JABS': WEIGHT-LOSS DRUGS SET FOR NEW BOOM AS GENERIC VERSIONS EMERGE

Generic versions of Wegovy, Saxenda, Ozempic, and Victoza are set to hit the market soon at a lower cost than the original drugs. Patents for liraglutide, which is in Victoza and Saxenda, have expired. Teva Pharmaceutical Industries, the world's largest generic drugmaker, has already launched a generic version of Victoza in the US. Pfizer, Viatris' Mylan, and Novartis' Sandoz are also planning to launch their own generic liraglutide products. Ozempic and Wegovy will lose patent protection in China in 2026, in Europe and Japan in 2031, and in the US in 2032.

theguardian.com · 8 min

TLDR

CLOUDFLARE DEBUTS ONE-CLICK NUKE OF WEB-SCRAPING AI

Cloudflare is now offering its web hosting customers a way to block AI bots from scraping website content and using the data without permission to train machine learning models. It is able to recognize bot activity even when operators lie about their user agent. The bot detection approach relies on digital fingerprinting. With a network that sees an average of 57 million requests per second, Cloudflare has ample data to determine which fingerprints can be trusted.

theregister.com · 3 min